Skip to main content
NCBI home page
Medical Science Monitor: International Medical Journal of Experimental and Clinical Research logoLink to Medical Science Monitor: International Medical Journal of Experimental and Clinical Research
. 2015 Apr 18;21:1097–1106. doi: 10.12659/MSM.893755

Association of Polymorphisms in Toll-Like Receptors 4 and 9 with Risk of Pulmonary Tuberculosis: A Meta-Analysis

Lianli Zhao 1,B,C,D,E,*, Kehun Liu 2,A,B,C,D,*, Xiangjun Kong A,B,C,D,E,F,G,✉, Zhenxia Tao 3,A,C,D,E, Yanxia Wang 3,D,E,F, Ying Liu 3,E,F
PMCID: PMC4412087  PMID: 25889916

Abstract

Background

Findings regarding the association of the single-nucleotide polymorphisms (SNPs) rs4986790 and rs4986791 in Toll-like receptor 4 and rs187084, rs574386, and rs352139 in Toll-like receptor 9 (TLR9) with pulmonary tuberculosis (PTB) susceptibility are inconsistent. We conducted a meta-analysis to systematically summarize and clarify the association between these SNPs and PTB susceptibility.

Material/Methods

A systematic literature search for relevant studies up to December, 2014 was performed in PubMed, EMBASE, Web of Science, Chinese National Knowledge Infrastructure (CNKI), and Wanfang databases. Information was gathered from each eligible study. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were used to pool the effect size.

Results

Finally, a total of 16 case-control studies on these polymorphisms were enrolled in this meta-analysis. The meta-analysis results suggest there was no association between these polymorphisms and PTB risk PTB risk in all the genetic models overall. However, for TLR4 rs4986791, a significant increased PTB risk was found in Africans, and for TLR9 rs352139 a significant increased PTB risk was found in Asians after subgroup analysis by ethnicity, although the enrolled studies were limited.

Conclusions

There was no association between the polymorphisms in TLR4 and 9 and PTB risk overall, but TLR4 rs4986791 and TLR9 rs352139 might be associated with increased PTB risk in Africans and Asians, respectively. Additional well-designed, larger-scale epidemiological studies are needed to validate our results.

MeSH Keywords: Meta-Analysis; Polymorphism, Single Nucleotide; Toll-Like Receptors; Tuberculosis, Pulmonary

Background

Tuberculosis (TB) caused by Mycobacterium tuberculosis (M. tb) still is a leading cause of morbidity and mortality worldwide [1]. M. tb infects one-third of the world population; however, only 10% of them progress to active TB, possibly due to complex environmental, genetic, and immunological interactions [2]. Host genetics are considered to play a critical role in the apparent differences in disease progression [3,4].

Toll-like receptors (TLRs), which are pathogen recognition receptors (PRRs), play an essential role in host innate response in the pathogenesis of TB. Currently, 11 mammalian TLRs have been identified and TLR 1–10 are functional in humans [5]. TLR1, TLR2, TLR4, TLR6, TLR8, and TLR9 are thought to be involved in the recognition of M. tb.

Activation of TLRs may result in several possible biological outcomes such as cytokine secretion, modulation of the adaptive immune response, rapid cellular differentiation, apoptosis, and direct antimicrobial activity [6–8]. M. tb cell-surface ligands interact with TLRs that can result in NF-κB activation and the production of proinflammatory cytokines, chemokines, and nitric oxide through myeloid differentiation primary response protein 88 (MyD88)-dependent or independent pathways [9–12].

It has been proposed that SNPs of TLR4 and TLR9 genes are associated with PTB susceptibility. TLR-knockout mouse studies indicate that TLR2, TLR4, and TLR9 contribute to host resistance to M. tb infection [13–17]. Recently, a series of studies have been conducted to investigate the association between the TLR4 and TLR9 polymorphisms and the risk of pulmonary tuberculosis (PTB) in diverse populations, but the results were mixed and inconclusive. Therefore, we performed a meta-analysis to evaluate the association of TLR4 and TLR9 SNPs with the susceptibility to PTB.

Material and Methods

Publication search

A systematic search was performed for published studies on the relationship between TLR9 polymorphisms and PTB susceptibility, without language restriction. PubMed, EMBASE, Web of Science, and 2 Chinese databases (Chinese National Knowledge Infrastructure and Wanfang databases) were utilized to search the available articles, with the last search update on September 30, 2014. The following terms were used: “Toll-like receptor 4 OR Toll-like receptor 9 OR TLR4 OR TLR9”, “tuberculosis”, and “polymorphism OR polymorphisms”, without any limitation applied. The articles retrieved were screened and selected independently by the 2 authors (L.Y. and K.X.J.) using eligibility criteria. The reference lists of selected articles and review articles were also examined to identify additional eligible studies.

Inclusion and exclusion criteria

Studies in this meta-analysis met the following inclusion criteria: (1) evaluated the relationship between TLR4 rs4986790 (Asp299Gly) and rs4986791 (Thr399Ile) and TLR9 rs352139, rs187084, and rs5743836 polymorphisms with tuberculosis susceptibility; (2) case-control study; (3) detailed genotype frequency data could be acquired to calculate the odds ratios (ORs) and 95% confidence intervals (CIs); and (4) original articles published in peer-reviewed journals. Exclusion criteria were: (1) studies that did not specify sample origins; (2) studies with no detailed genotype data; (3) studies with insufficient or duplicate data; (4) studies with same author from same country of origin. Two independent investigators selected the studies according to the inclusion and exclusion criteria by screening the title, abstract, and full text. Any dispute was resolved by discussion.

Data extraction

The following information was collected in duplicate by 2 investigators independently (Z.L.L. and L.K.H.) according to the criteria described above: name of first author, year of publication, the characteristics of cases and controls, country of origin, the detective sample, ethnicity, genotyping methods, Hardy-Weinberg equilibrium, number of cases and controls, and genotype frequency in cases and controls of the selected polymorphisms. For those studies that included subjects of PTB, extra-pulmonary tuberculosis, and tuberculosis meningitis, only the data on PTB cases and healthy controls were collected. If there was a disagreement about data, the 2 investigators rechecked the original data of the included studies and had a discussion to reach consensus; otherwise, the third investigator adjudicated the disagreements (K.X.J.).

Quality score assessment

Two investigators (T.Z.X. and W.Y.X.) assessed the methodological quality of each eligible article included in this meta-analysis according the Newcastle Ottawa Scale (NOS) based on 3 aspects: selection, comparability, and exposure, with scores ranging from 0 to 9 [18]. The standard of high quality was NOS score ≥7.

Statistical analysis

Initially, Hardy-Weinberg equilibrium (HWE) for each study was assessed by chi-square test in the control groups, and P<0.05 was considered as deviation from HWE. The crude odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated to assess the strength of association between the included polymorphisms and PTB risk. A p-value <0.05 was considered to indicate statistically significant association. Studies with zero value in both groups were excluded from meta-analysis, for such studies do not provide any indication of either the direction or magnitude of gene and disease association. Pooled ORs were performed for allelic comparison, homozygote model, heterozygote model, dominant model, and recessive model. The statistical significance level was determined by Z-test with P value less than 0.05. The chi-square based on Q statistic test was used for the assessment of heterogeneity and P<0.1 was considered statistically significant. When the effect was assumed to be lack of heterogeneity, the fixed-effects model (Mantel-Haenszel method) was used to calculate the pooled OR and 95% CIs; otherwise, the random-effects model (DerSimonian-Laird method) was used [19]. Sensitivity analysis was also conducted to evaluate the effect of each study on the combined ORs by omitting each study in each turn. Subgroup analysis was also performed to assess the ethnic-specific effect. Potential publication bias was checked by Begg’s funnel plots and Egger’s test [20,21]. An asymmetric plot and the P value of Egger’s test less than 0.05 was considered representative of statistically significant publication bias. All analyses were done using Stata 12.0 software (StataCorp, College Station, TX, USA). A 2-tailed P<0.05 was considered significant except for specific conditions, where a certain P value would be declared.

Results

Study characteristics

The literature selection process is shown in Figure 1. We initially identified 332 relevant articles. After excluding overlap between the databases, 273 abstracts were evaluated. Subsequently, 22 articles with full texts that met the inclusion criteria were assessed. Then 10 of the remaining 27 articles were excluded, among which, 1 had no relation to tuberculosis [22], 2 had duplicate data [23,24], 2 were not related to the included SNPs [25,26], and 4 did not present specific data on the included SNPs genotype [27–31]. Finally, a total of 12 eligible articles were included in the current meta-analysis [32–43].

Figure 1.

Figure 1

Open in a new tab

Flow chart of study selection.

The characteristics of each included study are listed in Table 1. There were 32 case-control studies published from 2004 to 2013. We finally analyzed 14 studies containing 2801 cases and 2590 controls for rs4986790, 8 studies containing 2137 cases and 1656 controls for rs4986791, 4 studies containing 1103 cases and 1301 controls for rs352139, 3 studies containing 635 cases and 696 controls for rs187084, and 3 studies containing 608 cases and 633 controls for rs5743836. Different genotyping methods, including polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), TaqMan, DigiTag2, and Illumina GoldenGate genotyping assay were utilized. The genotyping distribution was in agreement with HWE in all studies. The methodological quality scores of all included studies ranged from 7 to 9, with all the studies identified to be high quality.

Table 1.

Characteristics of the studies included in the meta-analysis.

Study ID Year Country Ethnicity Case Control P for HWE Quality
TLR4 rs4986790 AA AG GG AA AG GG
 Newport et al. 2004 Gambia African 241 62 4 235 58 5 0.814 8
 Fitness et al. 2004 Malawi African 146 16 0 389 38 0 0.629 8
 Rosas Taraco et al. 2007 Mexico Caucasian 94 10 0 110 4 0 0.982 7
 Ma et al. 2007 USA African 281 57 1 157 36 1 0.783 8
 Ma et al. 2007 USA Caucasian 159 20 1 95 14 1 0.84 7
 Ma et al. 2007 USA Caucasian 353 22 0 106 8 0 0.927 7
 Olesen et al. 2007 Guinea Bissau African 262 51 2 265 65 7 0.459 7
 Najmi et al. 2010 India Asian 95 34 6 206 44 0 0.312 8
 Selvaraj et al. 2010 India Asian 153 47 4 151 53 3 0.791 8
 Sanchez et al. 2012 Colombia Caucasian 429 36 1 270 29 1 0.973 9
 Jahantigh et al. 2013 Iran Asian 122 2 0 146 3 0 0.992 8
 Torres-garcia et al. 2013 Mexico Caucasian 88 2 0 89 1 0 0.989 7
TLR4 rs4986791 CC CT TT CC CT TT
 Ma et al. 2007 USA African 325 14 0 178 16 0 0.836 8
 Ma et al. 2007 USA Caucasian 161 18 1 97 12 1 0.675 8
 Ma et al. 2007 USA Caucasian 357 18 0 108 6 0 0.959 8
 Olesen et al. 2007 Guinea Bissau African 262 51 2 265 65 7 0.459 9
 Najmi et al. 2010 India Asian 105 26 4 206 43 1 0.731 7
 Selvaraj et al. 2010 India Asian 150 49 4 152 46 5 0.798 8
 Sanchez et al. 2012 Colombia Caucasian 429 36 1 272 26 1 0.905 9
 Jahantigh et al. 2013 Iran Asian 112 10 2 141 7 1 0.054 8
TLR9 rs352139 AA AG GG AA AG GG
 Kobayashi et al. 2011 Indonesia Asian 199 279 59 259 233 68 0.386 8
 Kobayashi et al. 2011 Vietnamese Asian 123 125 28 232 183 40 0.902 8
 Torres-Garcia et al. 2013 Mexico Caucasian 23 48 19 14 41 35 0.942 7
 Yang et al. 2013 China Asian 70 89 41 68 95 33 1.000 8
TLR9 rs187084 CC CT TT CC CT TT
 Olesen et al. 2007 Guinea-Bissau African 25 122 171 21 132 186 0.931 8
 Selvaraj et al. 2010 India Asian 27 91 75 32 92 84 0.718 8
 Jahantigh et al. 2013 Iran Asian 10 51 63 8 59 82 0.822 9
TLR9 rs5743836 CC CT TT CC CT TT
 Olesen et al. 2007 Guinea-Bissau African 62 154 104 66 175 101 0.818 8
 Selvaraj et al. 2010 India Asian 1 29 168 2 32 167 0.945 8
 Torres-Garcia et al. 2013 Mexico Caucasian 0 8 82 0 12 78 0.795 7
Open in a new tab

HWE – Hardy-Weinberg equilibrium.

Tests of heterogeneity

Significant heterogeneities for rs4986790 were found in the overall analyses under allelic model and for rs352139 in the overall analyses under 5 genetic models (Figure 2, Table 2). After subgroup analysis by ethnicity, for rs4986790, significant heterogeneities only existed in Asians, and for rs352139 most of the heterogeneity could be eliminated through ethnicity-specific analyses. For the other polymorphisms – rs4986791, rs187084, and rs5743836 – no heterogeneity was found in the overall analyses using 5 genetic models.

Figure 2.

Figure 2

Open in a new tab

Forest plot of allele comparison of rs4986790 and rs4986791 in TLR4 and rs352139, rs187084, and rs5743836 in TLR9.

Table 2.

Summary of pooled ORs in the meta-analysis.

Genotype Studies Comparison model N OR (95%CI) POR M I2 (%) PH
TLR4 rs4986790 Overall G vs. A 12 1.012 (0.812–1.261) 0.915 R 44.3 0.049
GG vs. AA 7 1.098 (0.588–2.049) 0.770 F 29.1 0.206
GA vs. AA 12 0.981 (0.832–1.157) 0.819 F 0.0 0.469
GG vs. GA+AA 7 1.098 (0.578–2.054) 0.769 F 24.8 0.240
GG+GA vs. AA 12 0.985 (0.838–1.157) 0.853 F 26.8 0.182
African G vs. A 4 0.884 (0.720–1.085) 0.520 F 0.0 0.520
GG vs. AA 3 0.502 (0.198–1.273) 0.147 F 0.0 0.638
GA vs. AA 4 0.930 (0.742–1.165) 0.525 F 0.0 0.728
GG vs. GA+AA 3 0.510 (0.201–1.293) 0.156 F 0.0 0.666
GG+GA vs. AA 4 0.902 (0.723–1.125) 0.360 F 0.0 0.614
Caucasian G vs. A 5 0.923 (0.661–1.288) 0.341 F 11.3 0.341
GG vs. AA 2 0.613 (0.086–4.378) 0.626 F 0.0 0.979
GA vs. AA 5 0.941 (0.663–1.337) 0.735 F 11.8 0.339
GG vs. GA+AA 2 0.626 (0.088–4.465) 0.640 F 0.0 0.978
GG+GA vs. AA 5 0.931 (0.658–1.3160 0.684 F 13.1 0.330
Asian G vs. A 3 1.313 (0.655–2.634) 0.443 R 73.8 0.022
GG vs. AA 2 4.824 (0.213–109.508) 0.808 R 73.4 0.053
GA vs. AA 3 1.144 (0.821–1.159) 0.427 F 45.3 0.161
GG vs. GA+AA 2 4.590 (0.235–89.760) 0.315 R 70.9 0.064
GG+GA vs. AA 3 1.249 (0.651–2.397) 0.503 R 64.8 0.059
TLR4 rs4986791 Overall T vs. C 8 0.919 (0.764–1.107) 0.374 F 36.1 0.141
TT vs. CC 6 0.946 (0.465–1.926) 0.879 F 23.9 0.255
TC vs. CC 8 0.921 (0.749–1.131) 0.432 F 0.0 0.474
TT vs. CT+CC 6 0.946 (0.464–1.926) 0.878 F 20.4 0.280
TT+CT vs. CC 8 0.922 (0.755–1.127) 0.427 F 20.4 0.267
African T vs. C 2 0.656 (0.474–0.908) 0.011 F 0.0 0.381
TT vs. CC 1 –
TC vs. CC 2 0.709 (0.497–1.011) 0.058 F 27.2 0.241
TT vs. CT+CC 1 –
TT+CT vs. CC 2 0.678 (0.479–0.960) 0.028 F 5.8 0.303
Caucasian T vs. C 3 0.884 (0.609–1.285) 0.519 F 0.0 0.995
TT vs. CC 2 0.618 (0.087–4.412) 0.631 F 0.0 0.980
TC vs. CC 3 0.890 (0.599–1.321) 0.562 F 0.0 0.997
TT vs. CT+CC 2 0.625 (0.088–4.457) 0.639 F 0.0 0.980
TT+CT vs. CC 3 0.878 (0.595–1.296) 0.513 F 0.0 0.997
Asian T vs. C 3 1.225 (0.921–1.631) 0.163 F 2.2 0.360
TT vs. CC 3 1.780 (0.685–4.628) 0.237 F 36.6 0.206
TC vs. CC 3 1.184 (0.851–1.647) 0.317 F 0.0 0.661
TT vs. CT+CC 3 1.736 (0.669–4.505) 0.257 F 36.0 0.210
TT+CT vs. CC 3 1.233 (0.898–1.694) 0.195 F 0.0 0.500
TLR9 rs352139 Overall G vs. A 4 1.021 (0.798–1.307) 0.866 R 72.5 0.012
GG vs. AA 4 0.977 (0.621–1.539) 0.921 R 62.0 0.048
GA vs. AA 4 1.193 (0.890–1.600) 0.237 R 55.4 0.081
GG vs. GA+AA 4 0.901 (0.601–1.349) 0.612 R 61.9 0.049
GG+GA vs. AA 4 1.137 (0.841–1.538) 0.404 R 62.1 0.048
Asian G vs. A 3 1.170 (1.033–1.326) 0.014 F 0.0 0.790
GG vs. AA 3 1.196 (0.907–1.578) 0.204 F 0.0 0.898
GA vs. AA 3 1.338 (1.118–1.602) 0.002 F 52.4 0.113
GG vs. GA+AA 3 1.049 (0.811–1.358) 0.714 F 0.0 0.480
GG+GA vs. AA 3 1.313 (1.107–1.558) 0.002 F 23.1 0.272
TLR9 rs187084 Overall C vs. T 3 1.070 (0.906–1.265) 0.425 F 0.0 0.774
CC vs. TT 3 1.172 (0.792–1.736) 0.428 F 0.0 0.600
CT vs. TT 3 1.059 (0.843–1.330) 0.625 F 0.0 0.905
CC vs. CT+TT 3 1.122 (0.772–1.630) 0.546 F 0.0 0.527
CC+CT vs. TT 3 1.079 (0.868–1.340) 0.494 F 0.0 0.908
Asian C vs. T 2 1.068 (0.850–1.342) 0.575 F 0.0 0.475
CC vs. TT 2 1.095 (0.657–1.823) 0.728 F 0.0 0.356
CT vs. TT 2 1.115 (0.807–1.541) 0.509 F 0.0 0.963
CC vs. CT+TT 2 1.026 (0.636–1.655) 0.917 F 0.0 0.739
CC+CT vs. TT 2 1.113 (0.819–1.513) 0.492 F 0.0 0.334
TLR9 rs5743836 Overall C vs. T 3 0.195 (0.753–1.111) 0.371 F 0.0 0.722
CC vs. TT 2 0.893 (0.579–1.378) 0.61 F 0.0 0.627
CT vs. TT 3 0.893 (0.579–1.378) 0.61 F 0.0 0.815
CC vs. CT+TT 2 0.986 (0.674–1.443) 0.944 F 0.0 0.580
CC+CT vs. TT 3 0.850 (0.649–1.112) 0.235 F 0.0 0.818
Open in a new tab

PH – P value of heterozygote.

Meta-analysis results

The association between the included polymorphisms and the susceptibility to PTB was first analyzed. As shown in Figure 2 and Table 2, no significant association was identified for any polymorphisms in overall analyses in any genetic model. Next, we performed subgroup analysis according to ethnicity, and significant association was still not found between the polymorphisms rs4986790, rs187084, and rs573836 and PTB risk in diverse populations. For TLR4 rs4986791, a significant decreased risk was observed in Africans in allele and dominant models. However, there were only 2 studies that analyzed in Africans, suggesting the results was not very convincing and further studied are need to verify the conclusion. For TLR9 rs352139, the association with PTB risk was found to be significant in allelic, heterozygote, and dominant models.

Publication bias

Begg’s funnel plot and Egger’s test were carried out to assess the publication bias among the selected studies for the polymorphisms rs4986790 and rs4986791 in TLR4 and rs352139 in TLR9. Symmetrical funnel plots were obtained in all the genetic models (Figure 3). The Egger’s test was also performed to provide the statistical evidence of publication bias. The findings showed lack of publication bias for all the included polymorphisms among all comparison genetic models except for TLR9 rs352139 in dominant model (PBegg=0.089, PEgger=0.002). No funnel plot or Egger’s test were performed for the association between rs187084 and rs5743836 and PTB susceptibility due to the limited number of included studies.

Figure 3.

Figure 3

Open in a new tab

Publication bias analysis for rs4986790 and rs4986791 in TLR4 and rs352139, rs187084, and rs5743836 in TLR9 in allele model.

Sensitivity analysis

Sensitivity analysis was performed to examine the influence of any individual study on the pooled ORs for the polymorphisms rs4986790 and rs4986791 in TLR4 and rs352139 in TLR9 by deleting each study once in every genetic model, and we arrived at almost the same results (Figure 4 and data not shown).

Figure 4.

Figure 4

Open in a new tab

Sensitivity analysis for rs4986790 and rs4986791 in TLR4 and rs352139 in TLR9 in allele model.

Discussion

In the present meta-analysis, we pooled a total of 32 case-control studies to evaluate the association of rs4986790 and rs4986791 polymorphisms in TLR4 and rs352139, rs187084, and rs5743836 polymorphisms in TLR9 with PTB susceptibility, and found that none the included polymorphisms were associated with PTB risk in overall analysis under all 5 genetic models. After subgroup analysis according to ethnicity, we found that TLR4 rs4986791 and TLR9 rs352139 might contribute to PTB infection in Africans and Asians, respectively.

Both innate and adaptive immune responses determine the development and outcomes of PTB. Toll-like receptors, including TLR4 and TLR9, have been considered to be involved in response to M. tb. TLR4 can recognize lipopolysaccharide, mycobacterial cell wall components, and heat-labile soluble mycobacterial factor to initiate the innate responses against tuberculosis, while TLR9 can recognize unmethylated CpG motifs in bacterial DNA and is essential for cellular responses to mycobacterial CpG DNA [44]. It has been reported that TLR2 or/and TLR9 deficiency makes mice susceptible to M. tb infection [17]. TLR4 and TLR9 activation is essential for the maintenance of M. tb Ag elicited pulmonary granulomatous response; however, the underlying mechanism is unknown. A series of SNPs have been identified, including rs4986790 (Asp299Gly, +896A>G) and rs4986791 (Thr399Ile, +1196C>T) in TLR4 and rs187084 (C-1486T), rs5743836 (C-1237T), rs352139 (G+1174A), and rs352140 (G+2848A) in TLR9 in different ethnicities (45). Rs4986790 and rs4986791 polymorphisms in TLR4 are the most widely studied and have been implicated in several diseases, including carcinomas. Rs187084 and rs5743836 polymorphisms of TLR9 are located within the putative promoter region of the gene that may influence the transcriptional regulation of the TLR9 gene by altering the binding of transcription factors. In contrast, rs352139 and rs352140 in the introns may affect mRNA splicing and/or enhance TLR9 gene transcription.

The functional evidence supports that TLR4 and TLR9 are genetic components in the risk of PTB, and the association of several SNPs with PTB susceptibility has been determined. However, the recent studies on TLR4 and TLR9 gene polymorphisms with PTB sociability are still contradictory because a single case-control study only provides a small test power due to a limited sample size. In this study, we performed a systematic search in several electronic databases, including PubMed, Web of Science, CNKI, and Wanfang database, on the association of TLR4 and TLR9 polymorphisms with PTB up to December, 2014. Finally, 16 articles with a total of 32 case-control studies containing a total of 14 160 participants were enrolled in this meta-analysis. After pooling independent analyses, we did not find any associations of TLR4 and TLR9 polymorphisms with the susceptibility to PTB overall under all the genetic models. However, further subgroup analysis suggested TLR4 rs4986791 was correlated with PTB risk in Africans under allelic and dominant models, and TLR9 rs352139 polymorphism was correlated with PTB risk in Asians under allelic, heterozygote, and dominant models.

Recently, several genome-wide association studies have been performed to indentify the SNPs that influence PTB susceptibility [46,47]. However, no polymorphisms in TLR4 and TLR9 were identified to be significantly related to PTB risk, which might due to sample size, ethnicity, or geographical limitations. Unfortunately, we could obtain the genotype frequencies in the GWAS studies related to the polymorphisms in TLR4 and TLR9. To the best of our knowledge, the present study is the most recent meta-analysis to address the association of TLR4 polymorphisms and PTB risk. In a previous meta-analysis that enrolled the articles related to TLR4 polymorphism and PTB risk up to February 2012, the researchers found no association between TLR4 rs4986790 and rs4986791 polymorphism and PTB; however, subgroup analysis were not performed. In the present meta-analysis, we included the related studies up to December 2014 and verified the conclusions. Furthermore, we performed subgroup analysis according to ethnicity and found a decreased risk of PTB in Africans who harbor rs4986791 polymorphism, although there were few enrolled studies, suggesting more attention should be paid to the association of rs4986791 and PTB risk. In contrast, this is the first meta-analysis to investigate the association of TLR 9 polymorphisms with PTB susceptibility. There are some limitations in our meta-analysis that should be considered. Firstly, the number of the included studies limited further analysis and made the results tentative. Secondly, we did not perform an evaluation of potential interactions such as polymorphism-polymorphism, gene-gene, and gene-environment due to the lack of sufficient data. Further well-designed case-control studies with larger sample sizes focusing on diverse populations should be conducted to confirm the results.

Conclusions

Our comprehensive conclusion from the current meta-analysis is that TLR4 rs4986791 might correlate with the decreased risk of PTB in Africans, and TLR9 rs352139 polymorphism might associate with the increased risk of PTB in Asians, but rs4986790, rs187084, and rs5743836 were not independent risk factors for PTB susceptibility.

Footnotes

Conflict of interest

We declare no conflict of interest.

Source of support: Departmental sources

Reference

  • 1.Russell DG, VanderVen BC, Lee W, et al. Mycobacterium tuberculosis wears what it eats. Cell Host Microbe. 2010;8:68–76. doi: 10.1016/j.chom.2010.06.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Stop TB partnership: The global plan to Stop TB 2011. –2015 [Google Scholar]
  • 3.McShane H. Susceptibility to tuberculosis – the importance of the pathogen as well as the host. Clin Exp Immunol. 2003;133:20–21. doi: 10.1046/j.1365-2249.2003.02194.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Boechat AL, Ogusku MM, Sadahiro A, dos Santos MC. Association between the PTPN22 1858C/T gene polymorphism and tuberculosis resistance. Infect Genet Evol. 2013;16:310–13. doi: 10.1016/j.meegid.2013.02.019. [DOI] [PubMed] [Google Scholar]
  • 5.Thada S, Valluri VL, Gaddam SL. Influence of Toll-like receptor gene polymorphisms to tuberculosis susceptibility in humans. Scand J Immunol. 2013;78:221–29. doi: 10.1111/sji.12066. [DOI] [PubMed] [Google Scholar]
  • 6.Liu G, Zhang L, Zhao Y. Modulation of immune responses through direct activation of Toll-like receptors to T cells. Clin Exp Immunol. 2010;160:168–75. doi: 10.1111/j.1365-2249.2010.04091.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Lisa C, Moira K, Steven K, Ian S. The expression and roles of Toll-like receptors in the biology of the human neutrophil. J Leuko Biol. 2005;77:886–92. doi: 10.1189/jlb.1104636. [DOI] [PubMed] [Google Scholar]
  • 8.Krutzik SR, Modlin RL. The role of Toll-like receptors in combating mycobacteria. Semin Immunol. 2004;16:35–41. doi: 10.1016/j.smim.2003.10.005. [DOI] [PubMed] [Google Scholar]
  • 9.Jo EK. Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs. Curr Opin Infect Dis. 2008;21:279–86. doi: 10.1097/QCO.0b013e3282f88b5d. [DOI] [PubMed] [Google Scholar]
  • 10.Yamamoto M, Sato S, Hemmi H, et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 2003;301:640–43. doi: 10.1126/science.1087262. [DOI] [PubMed] [Google Scholar]
  • 11.Xu Y, Jagannath C, Liu XD, Sharafkhaneh A, et al. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity. 2007;27:135–44. doi: 10.1016/j.immuni.2007.05.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Covert MW, Leung TH, Gaston JE, Baltimore D. Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science. 2005;309:1854–57. doi: 10.1126/science.1112304. [DOI] [PubMed] [Google Scholar]
  • 13.Reiling N, Holscher C, Fehrenbach A, et al. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol. 2002;169:3480–84. doi: 10.4049/jimmunol.169.7.3480. [DOI] [PubMed] [Google Scholar]
  • 14.Drennan MB, Nicolle D, Quesniaux VJ, et al. Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am J Pathol. 2004;164:49–57. doi: 10.1016/S0002-9440(10)63095-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Sugawara I, Yamada H, Li C, et al. Mycobacterial infection in TLR2 and TLR6 knockout mice. Microbiol Immunol. 2003;47:327–36. doi: 10.1111/j.1348-0421.2003.tb03404.x. [DOI] [PubMed] [Google Scholar]
  • 16.Abel B, Thieblemont N, Quesniaux VJ, et al. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol. 2002;169:3155–62. doi: 10.4049/jimmunol.169.6.3155. [DOI] [PubMed] [Google Scholar]
  • 17.Bafica A, Scanga CA, Feng CG, et al. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med. 2005;202:1715–24. doi: 10.1084/jem.20051782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. http://www.ohri.ca/program/clinical_epidemiology/oxford.htm.
  • 19.DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88. doi: 10.1016/0197-2456(86)90046-2. [DOI] [PubMed] [Google Scholar]
  • 20.Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101. [PubMed] [Google Scholar]
  • 21.Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34. doi: 10.1136/bmj.315.7109.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Lee PL, West C, Crain K, Wang L. Genetic polymorphisms and susceptibility to lung disease. J Negat Results Biomed. 2006;5:5. doi: 10.1186/1477-5751-5-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Collins RL, Hu T, Wejse C, et al. Multifactor dimensionality reduction reveals a three-locus epistatic interaction associated with susceptibility to pulmonary tuberculosis. BioData Min. 2013;6:4. doi: 10.1186/1756-0381-6-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Velez DR, Hulme WF, Myers JL, et al. NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans. Hum Genet. 2009;126:643–53. doi: 10.1007/s00439-009-0713-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Arji N, Busson M, Iraqi G, et al. Genetic diversity of TLR2, TLR4, and VDR loci and pulmonary tuberculosis in Moroccan patients. J Infect Dev Ctries. 2014;8:430–40. doi: 10.3855/jidc.3820. [DOI] [PubMed] [Google Scholar]
  • 26.Zaki HY, Leung KH, Yiu WC, et al. Common polymorphisms in TLR4 gene associated with susceptibility to pulmonary tuberculosis in the Sudanese. Int J Tuberc Lung Dis. 2012;16:934–40. doi: 10.5588/ijtld.11.0517. [DOI] [PubMed] [Google Scholar]
  • 27.Velez DR, Wejse C, Stryjewski ME, et al. Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans. Hum Genet. 2010;127:65–73. doi: 10.1007/s00439-009-0741-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Bharti D, Kumar A, Mahla RS, et al. The role of TLR9 polymorphism in susceptibility to pulmonary tuberculosis. Immunogenetics. 2014;66(12):675–81. doi: 10.1007/s00251-014-0806-1. [DOI] [PubMed] [Google Scholar]
  • 29.Xue Y, Zhao ZQ, Wang HJ, et al. Toll-like receptors 2 and 4 gene polymorphisms in a southeastern Chinese population with tuberculosis. Int J Immunogenet. 2010;37:135–38. doi: 10.1111/j.1744-313X.2009.00892.x. [DOI] [PubMed] [Google Scholar]
  • 30.Ferwerda B, Kibiki GS, Netea MG, et al. The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania. AIDS. 2007;21:1375–77. doi: 10.1097/QAD.0b013e32814e6b2d. [DOI] [PubMed] [Google Scholar]
  • 31.Pulido I, Leal M, Genebat M, et al. The TLR4 ASP299GLY polymorphism is a risk factor for active tuberculosis in Caucasian HIV-infected patients. Curr HIV Res. 2010;8:253–58. doi: 10.2174/157016210791111052. [DOI] [PubMed] [Google Scholar]
  • 32.Kobayashi K, Yuliwulandari R, Yanai H, et al. Association of TLR polymorphisms with development of tuberculosis in Indonesian females. Tissue Antigens. 2012;79:190–97. doi: 10.1111/j.1399-0039.2011.01821.x. [DOI] [PubMed] [Google Scholar]
  • 33.Olesen R, Wejse C, Velez DR, et al. DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans. Genes Immun. 2007;8:456–67. doi: 10.1038/sj.gene.6364410. [DOI] [PubMed] [Google Scholar]
  • 34.Selvaraj P, Harishankar M, Singh B, et al. Toll-like receptor and TIRAP gene polymorphisms in pulmonary tuberculosis patients of South India. Tuberculosis (Edinb) 2010;90:306–10. doi: 10.1016/j.tube.2010.08.001. [DOI] [PubMed] [Google Scholar]
  • 35.Torres-Garcia D, Cruz-Lagunas A, Garcia-Sancho Figueroa MC, et al. Variants in toll-like receptor 9 gene influence susceptibility to tuberculosis in a Mexican population. J Transl Med. 2013;11:220. doi: 10.1186/1479-5876-11-220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Yang Y, Li X, Cui W, et al. Potential association of pulmonary tuberculosis with genetic polymorphisms of toll-like receptor 9 and interferon-gamma in a Chinese population. BMC Infect Dis. 2013;13:511. doi: 10.1186/1471-2334-13-511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Jahantigh D, Salimi S, Alavi-Naini R, et al. Association between TLR4 and TLR9 gene polymorphisms with development of pulmonary tuberculosis in Zahedan, southeastern Iran. ScientificWorldJournal. 2013;2013:534053. doi: 10.1155/2013/534053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Sanchez D, Lefebvre C, Rioux J, et al. Evaluation of Toll-like receptor and adaptor molecule polymorphisms for susceptibility to tuberculosis in a Colombian population. Int J Immunogenet. 2012;39:216–23. doi: 10.1111/j.1744-313X.2011.01077.x. [DOI] [PubMed] [Google Scholar]
  • 39.Ma X, Liu Y, Gowen BB, et al. Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease. PLoS One. 2007;2:e1318. doi: 10.1371/journal.pone.0001318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Najmi N, Kaur G, Sharma SK, Mehra NK. Human Toll-like receptor 4 polymorphisms TLR4 Asp299Gly and Thr399Ile influence susceptibility and severity of pulmonary tuberculosis in the Asian Indian population. Tissue Antigens. 2010;76:102–9. doi: 10.1111/j.1399-0039.2010.01481.x. [DOI] [PubMed] [Google Scholar]
  • 41.Newport MJ, Allen A, Awomoyi AA, et al. The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia. Tuberculosis (Edinb) 2004;84:347–52. doi: 10.1016/j.tube.2004.02.001. [DOI] [PubMed] [Google Scholar]
  • 42.Rosas-Taraco AG, Revol A, Salinas-Carmona MC, et al. CD14 C(−159)T polymorphism is a risk factor for development of pulmonary tuberculosis. J Infect Dis. 2007;196:1698–706. doi: 10.1086/522147. [DOI] [PubMed] [Google Scholar]
  • 43.Fitness J, Floyd S, Warndorff DK, et al. Large-scale candidate gene study of tuberculosis susceptibility in the Karonga district of northern Malawi. Am J Trop Med Hyg. 2004;71:341–49. [PubMed] [Google Scholar]
  • 44.Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol. 2002;20:709–60. doi: 10.1146/annurev.immunol.20.100301.064842. [DOI] [PubMed] [Google Scholar]
  • 45.Lazarus R, Klimecki WT, Raby BA, et al. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics. 2003;81:85–91. doi: 10.1016/s0888-7543(02)00022-8. [DOI] [PubMed] [Google Scholar]
  • 46.Thye T, Vannberg FO, Wong SH, et al. Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat Genet. 2010;42:739–41. doi: 10.1038/ng.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Png E, Alisjahbana B, Sahiratmadja E, et al. A genome wide association study of pulmonary tuberculosis susceptibility in Indonesians. BMC Med Genet. 2012;13:5. doi: 10.1186/1471-2350-13-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Medical Science Monitor : International Medical Journal of Experimental and Clinical Research are provided here courtesy of International Scientific Information, Inc.

RESOURCES